{"product_id":"cardiac-biomarkers-technologies-and-global-markets","title":"Cardiac Biomarkers: Technologies and Global Markets","description":"\u003cp\u003eCompanies Mentioned\u003c\/p\u003e\n\n\u003cp\u003eAbbott Laboratories\u003cbr\u003e\nAcs Biomarker Bv\u003cbr\u003e\nBeckman Coulter (Subsidiary Of Danaher Corp.)\u003cbr\u003e\nBg Medicine Inc.\u003cbr\u003e\nBio-rad Laboratories, Inc.\u003cbr\u003e\nBiomerieux S.A.\u003cbr\u003e\nCardiogenics\u003cbr\u003e\nCreative Diagnostics\u003cbr\u003e\nCritical Diagnostics\u003cbr\u003e\nLife Diagnostics Inc.\u003cbr\u003e\nLifesign\u003cbr\u003e\nLsi Medience Corp.\u003cbr\u003e\nMeridian Life Science Inc.\u003cbr\u003e\nMetanomics Health Gmbh\u003cbr\u003e\nOrtho-clinical Diagnostics Inc.\u003cbr\u003e\nPerkinelmer Inc.\u003cbr\u003e\nPts Diagnostics\u003cbr\u003e\nQuidel Corp.\u003cbr\u003e\nRadiometer Medical Aps\u003cbr\u003e\nRandox Laboratories Ltd.\u003cbr\u003e\nResponse Biomedical Corp.\u003cbr\u003e\nRoche Diagnostics\u003cbr\u003e\nSanyo Chemical Industries Ltd.\u003cbr\u003e\nSiemens Ag\u003cbr\u003e\nSingulex Inc.\u003cbr\u003e\nSpectral Medical Inc.\u003cbr\u003e\nThermo Fisher Scientific, Inc.\u003cbr\u003e\nTosoh Bioscience Inc.\u003cbr\u003e\nTrinity Biotech PlcReport Scope:\u003c\/p\u003e\n\n\u003cp\u003eThe scope of this report is\u003c\/p\u003e \n\n\u003cp\u003eIdentify viable technology drivers through a comprehensive look at various platform technologies for cardiac marker segments of the diagnostic testing market.\u003c\/p\u003e\n\n\u003cp\u003eObtain a complete understanding of the leading cardiac markers and their value in terms of diagnostic testing, screening, prognostic monitoring, pharmacogenomic testing and theragnostic, while also gaining an appreciation these elements from their basic principles to their applications.\u003c\/p\u003e\n\n\u003cp\u003eDiscover feasible market opportunities via the identification of high-growth applications in different cardiac marker diagnostic testing areas, with a focus on the biggest and fastest-expanding markets for diseases.\u003c\/p\u003e\n\n\u003cp\u003eFocus on global industry development through an in-depth analysis of the major world markets for cardiac marker diagnostic testing, including forecasts for growth.\u003c\/p\u003e\n\n\u003cp\u003ePresent market figures for the current value of the cardiac biomarkers market, projections and growth rates. These are developed from the most recently available information from the global diagnostics industry.\u003c\/p\u003e\n\n\u003cp\u003eBy purchasing this study, the reader will gain\u003c\/p\u003e \n\n\u003cp\u003eAn improved understanding of the current state and future of the most exciting cardiac biomarker market segments.\u003c\/p\u003e\n\n\u003cp\u003eThe latest information on the leading companies engaged in research and development (R\u0026amp;D) and products in the cardiac marker diagnostic reagent pipeline.\u003c\/p\u003e\n\n\u003cp\u003eKnowledge of the cardiac diagnostic testing market as an area of growth, research and investment.\u003c\/p\u003e\n\n\u003cp\u003eThis analysis covers the following categories of the cardiac biomarker segments\u003c\/p\u003e \n\n\u003cp\u003eAcute Myocardial Infarction (AMI).\u003c\/p\u003e\n\n\u003cp\u003eHeart failure.\u003c\/p\u003e\n\n\u003cp\u003eBrain natriuretic peptide (BNP).\u003c\/p\u003e\n\n\u003cp\u003eMyoglobin.\u003c\/p\u003e\n\n\u003cp\u003eHomocysteine (Hcy).\u003c\/p\u003e\n\n\u003cp\u003eC-reactive protein (CRP).\u003c\/p\u003e\n\n\u003cp\u003ePulmonary embolism (PE) D-dimer test.\u003c\/p\u003e\n\n\u003cp\u003eLow-density lipoproteins (LDL) and high-density lipoproteins (HDL).\u003c\/p\u003e\n\n\u003cp\u003eStroke.\u003c\/p\u003e\n\n\u003cp\u003eCreatine kinase-myocardial band (CK-MB) and cardiac enzymes.\u003c\/p\u003e\n\n\u003cp\u003eAlbumin.\u003c\/p\u003e\n\n\u003cp\u003eCardiac markers are used in clinical decisions.\u003c\/p\u003e\n\n\u003cp\u003eCardiac markers in renal failure.\u003c\/p\u003e\n\n\u003cp\u003eTroponins in non-ischemic heart disease.\u003c\/p\u003e\n\n\u003cp\u003eCardiac panels.\u003c\/p\u003e\n\n\u003cp\u003ePOC cardiac markers.\u003c\/p\u003e\n\n\u003cp\u003eAnalyses include charts and graphs measuring product growth and trends within the marketplace. In addition, a discussion of research on various illnesses provides the reader with a deeper understanding of the possibilities for future treatment and avenues for possible R\u0026amp;D budgets. Company-specific information, including sales figures, product pipeline status and R\u0026amp;D trends, is provided throughout the report. In addition, the study\u003c\/p\u003e \n\n\u003cp\u003eAssesses cardiac marker diagnostic testing market drivers and bottlenecks from the perspective of the medical and scientific communities.\u003c\/p\u003e\n\n\u003cp\u003eDiscusses the potential benefits of the cardiac marker diagnostic testing market for various sectors of the medical and scientific community.\u003c\/p\u003e\n\n\u003cp\u003eEstablishes the current total market size and future growth of the cardiac marker diagnostic testing market and analyzes the current size and growth of individual segments.\u003c\/p\u003e\n\n\u003cp\u003eProvides current and forecasted market shares by company.\u003c\/p\u003e\n\n\u003cp\u003eDiscusses profit and business opportunities by diagnostic testing segment.\u003c\/p\u003e\n\n\u003cp\u003eProvides strategic recommendations for near-term business opportunities.\u003c\/p\u003e\n\n\u003cp\u003eAssesses current commercial uses of the cardiac biomarker market.\u003c\/p\u003e\n\n\u003cp\u003eReport Includes:\u003c\/p\u003e\n\n\u003cp\u003e66 data tables and 36 additional tables\u003c\/p\u003e\n\n\u003cp\u003eAn up-to-date overview and analysis of the global markets for cardiac biomarkers technologies\u003c\/p\u003e\n\n\u003cp\u003eAnalyses of the global market trends, with historic revenue data for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027\u003c\/p\u003e\n\n\u003cp\u003eEstimation of the actual market size and revenue forecast for cardiac biomarkers market in USD million terms, and corresponding market share analysis based on the type of biomarker, instrument category, and region\u003c\/p\u003e\n\n\u003cp\u003eIdentification of the viable technology drivers and barriers through a holistic review of various platform technologies in cardiac biomarker measurement and their notable advancements\u003c\/p\u003e\n\n\u003cp\u003eComplete understanding of the leading cardiac markers and their value in terms of diagnostic testing, screening, prognostic monitoring, pharmacogenomic testing, and theranostics, while also appreciating these elements from their basic principles to their applications\u003c\/p\u003e\n\n\u003cp\u003eDiscussion of feasible market opportunities via identification of high-growth applications in different cardiac marker diagnostic testing areas, with a focus on the biggest and fastest-expanding markets for diseases\u003c\/p\u003e\n\n\u003cp\u003eEmphasis on global industry development through an in-depth analysis of the major world markets for cardiac marker diagnostic testing, including forecasts for growth\u003c\/p\u003e\n\n\u003cp\u003eLatest information on the leading companies engaged in research and development (R\u0026amp;D) and products in the cardiac marker diagnostic reagent pipeline with SWOT analyses\u003c\/p\u003e\n\n\u003cp\u003eReview of the patents and patent applications on cardiac biomarkers and deep dive of recent global and region-specific patent publications related to cardiac biomarkers\u003c\/p\u003e\n\n\u003cp\u003eInsight into the company competitive landscape and company value share analysis for the leading suppliers of cardiac biomarkers\u003c\/p\u003e\n\n\u003cp\u003eProfile descriptions of the major global players, including Abbott Laboratories, Beckman Coulter (subsidiary of Danaher Corp.), bioMérieux S.A., PerkinElmer Inc., Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific Inc.ABBOTT LABORATORIES\u003cbr\u003e\nACS BIOMARKER BV\u003cbr\u003e\nBECKMAN COULTER (SUBSIDIARY OF DANAHER CORP.)\u003cbr\u003e\nBG MEDICINE INC.\u003cbr\u003e\nBIO-RAD LABORATORIES, INC.\u003cbr\u003e\nBIOMERIEUX S.A.\u003cbr\u003e\nCARDIOGENICS\u003cbr\u003e\nCREATIVE DIAGNOSTICS\u003cbr\u003e\nCRITICAL DIAGNOSTICS\u003cbr\u003e\nLIFE DIAGNOSTICS INC.\u003cbr\u003e\nLIFESIGN\u003cbr\u003e\nLSI MEDIENCE CORP.\u003cbr\u003e\nMERIDIAN LIFE SCIENCE INC.\u003cbr\u003e\nMETANOMICS HEALTH GMBH\u003cbr\u003e\nORTHO-CLINICAL DIAGNOSTICS INC.\u003cbr\u003e\nPERKINELMER INC.\u003cbr\u003e\nPTS DIAGNOSTICS\u003cbr\u003e\nQUIDEL CORP.\u003cbr\u003e\nRADIOMETER MEDICAL APS\u003cbr\u003e\nRANDOX LABORATORIES LTD.\u003cbr\u003e\nRESPONSE BIOMEDICAL CORP.\u003cbr\u003e\nROCHE DIAGNOSTICS\u003cbr\u003e\nSANYO CHEMICAL INDUSTRIES LTD.\u003cbr\u003e\nSIEMENS AG\u003cbr\u003e\nSINGULEX INC.\u003cbr\u003e\nSPECTRAL MEDICAL INC.\u003cbr\u003e\nTHERMO FISHER SCIENTIFIC, INC.\u003cbr\u003e\nTOSOH BIOSCIENCE INC.\u003cbr\u003e\nTRINITY BIOTECH PLC\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"February, 2023 \/ 287 Pages \/ MCW16227110","offer_id":47645909811506,"sku":null,"price":6600.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/cardiac-biomarkers-technologies-and-global-markets","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}